This could touch 18-$20 before approval, $30+ when approved. Every PDUFA carries a risk, but Zalviso carries a much lower risk and should be approved due to the added benefit to restrict substance abuse. I would not be surprized for attempts to pick-up ACRX before approval given high approval likelihood.
We may see $15 well before PDUFA, JMO, wonder if there could be something in the works we don't know about yet. I am not complaining, but seems to be strengthening nice and steady and we are near breakout level. Again, just my thought.